XML 23 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Introduction
 6 Months Ended
Jun. 30, 2023
General Information About Financial Statements [Abstract]  
Introduction
INTRODUCTION
Sanofi, together with its subsidiaries (collectively “Sanofi”, “the Group” or “the Company”), is a global healthcare leader engaged in the research, development and marketing of therapeutic solutions focused on patient needs.
Sanofi is listed in Paris (Euronext: SAN) and New York (Nasdaq: SNY).
The condensed consolidated financial statements for the six months ended June 30, 2023 were reviewed by the Sanofi Board of Directors at the Board meeting on July 27, 2023.